-The Hindu The Union Cabinet on Wednesday approved the Rs. 22,507-crore National Urban Health Mission (NUHM) that seeks to address healthcare challenges in towns and cities with focus on urban poor. The Union Cabinet on Wednesday approved the Rs. 22,507-crore National Urban Health Mission (NUHM) that seeks to address healthcare challenges in towns and cities with focus on urban poor. The scheme will now be introduced as a sub-mission under the National...

-The Hindustan Times It now seems increasingly unlikely that Parliament will consider the National Food Security Bill during this budget session. In a land which for centuries suffered devastating famines, where chronic hunger continues to stalk more than 200 million people, and which is home to every third malnourished child on the planet, this would be one more sad betrayal of the country's indigent millions, a reminder of how little they...

-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...

-Economic and Political Weekly While the Supreme Court decision in the recent Novartis case has cleared the way for production of generic drugs in India, doctors have to prescribe cheaper alternatives to costly brands if patients with limited means are to benefit. What is being hailed as a victory in the struggle for affordable medicines in the country will actually be one only when there is a pro-patient slant to the...